MDSCs and tumor-associated platelets (TAPs) further contribute to breast cancer immune evasion by inhibiting T-cell and NK-cell activity, secreting immunosuppressive cytokines such as IL-10 and TGF-β, and promoting regulatory T-cell expansion. This evidence concerns the gene IL10 and breast carcinoma.